Tuesday, August 23, 2016

BRIEF-Cempra - EMA's CHMP will begin their assessment of Solithromycin

* Cempra announces European medicines agency validates MAA

for solithromycin for treatment of CABP

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)